| 1. |
国家卫生健康委办公厅 国家中医药管理局办公室. 新型冠状病毒感染的肺炎诊疗方案(试行第五版). http://www.gov.cn/zhengce/zhengceku/2020-02/05/5474791/files/de44557832ad4be1929091dcbcfca891.pdf[2020-02-04].
|
| 2. |
WuHan coronavirus outbreak. https://www.worldometers.info/.
|
| 3. |
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J/OL]. Lancet, 2020-01-30. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30211-7/fulltext.
|
| 4. |
Tamez-Perez HE, Quintanilla-Flores DL, Rodriguez-Gutierrez R, et al. Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: A narrative review. World J Diabetes, 2015, 6(8): 1073-1081.
|
| 5. |
Suh S, Park MK. Glucocorticoid-induced diabetes mellitus: an important but overlooked problem. Endocrinol Metab (Seoul), 2017, 32(2): 180-189.
|
| 6. |
Baker EH, Wood DM, Brennan AL, et al. Hyperglycaemia and pulmonary infection. Proc Nutr Soc, 2006, 65(3): 227-235.
|
| 7. |
McAlister FA, Majumdar SR, Blitz S, et al. The relation between hyperglycemia and outcomes in 2, 471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care, 2005, 28(4): 810-815.
|
| 8. |
Guo L, Wei D, Zhang X, et al. Clinical features predicting mortality risk in patients with viral pneumonia: The MuLBSTA Score. Front Microbiol, 2019, 10: 2752.
|
| 9. |
Griffiths MJD, McAuley DF, Perkins GD, et al. Guidelines on the Management of Acute Respiratory Distress Syndrome[J/OL].BMJ Open Respir Res , 2019-03-07. https://bmjopenrespres.bmj.com/content/bmjresp/6/1/e000420.full.pdf.
|
| 10. |
Arabi YM, Mandourah Y, Al-Hameed F, et al. Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome. Am J Respir Crit Care Med, 2018, 197(6): 757.
|
| 11. |
Brun-Buisson C, Richard JC, Mercat A, et al. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med, 2011, 183(9): 1200-1206.
|
| 12. |
Martin-Loeches I, Lisboa T, Rhodes A, et al. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med, 2011, 37(2): 272-283.
|
| 13. |
Xi XM, Xu Y, Jiang L, et al. Hospitalized adult patients with 2009 influenza A(H1N1) in Beijing, China: risk factors for hospital mortality. BMC Infect Dis, 2010, 10: 256.
|
| 14. |
Chen RC, Tang XP, Tan SY, et al. Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience. Chest, 2006, 129(6): 1441-1452.
|
| 15. |
Jung K, Alekseev KP, Zhang XS, et al. Altered pathogenesis of porcine respiratory coronavirus in pigs due to immunosuppressive effects of dexamethasone: implications for corticosteroid use in treatment of severe acute respiratory syndrome coronavirus. J Virol, 2007, 81(24): 13681-13693.
|
| 16. |
Lee N, Allen Chan KC, Hui DS, et al. Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients. J Clin Virol, 2004, 31: 304-309.
|
| 17. |
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J/OL]. Lancet, 2020-01-24. https://doi.org/10.1016/S0140-6736(20)30183-5.
|
| 18. |
Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury[J/OL]. Lancet, 2020-02-07. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30317-2/fulltext.
|
1/5
WeChat